Einecs 222-959-6 - Names and Identifiers
Einecs 222-959-6 - Physico-chemical Properties
Molecular Formula | C9H16O2
|
Molar Mass | 156.22 |
Density | 1.01g/cm3 |
Boling Point | 221.3°C at 760 mmHg |
Flash Point | 80.4°C |
Vapor Presure | 0.161mmHg at 25°C |
Refractive Index | 1.472 |
Einecs 222-959-6 - Introduction
2-[(cyclohexyloxy)methyl]oxirane, the chemical name is 2-[(cyclohexyloxy)methyl]oxirane, is an organic compound. The following is a description of the properties, uses, preparation and safety information of the compound:
Nature:
2-[(cyclohexyloxy)methyl]oxirane is a colorless to light yellow liquid with an ether-like odor. It has low volatility and high solvent resistance, is relatively stable, and is soluble in a wide range of organic solvents.
Use:
2-[(cyclohexyloxy)methyl]oxirane has good fluidity and wettability, so it is often used as a solubilizer, cosolvent and dispersant in coatings and inks. At the same time, it is also commonly used as an additive in industries such as dyes, pharmaceuticals and cosmetics.
Preparation Method:
2-[(cyclohexyloxy)methyl]oxirane can be prepared by reacting a glycidyl ester with cyclohexanol. The specific steps are: adding glycidyl ester and cyclohexanol into a reaction kettle, then adding a catalyst, performing the reaction at an appropriate temperature, and then performing separation and purification to obtain the product.
Safety Information:
The 2-[(cyclohexyloxy)methyl]oxirane is relatively safe under normal conditions of use. However, as an organic substance, it may cause irritation to the skin, eyes and respiratory tract. Therefore, appropriate personal protective measures should be taken during use, such as wearing protective glasses, gloves and protective clothing. In the process of handling, attention should be paid to avoid inhalation of gas or dust, and avoid prolonged contact and intake. If necessary, it should be used in a well-ventilated place, and emergency treatment should be carried out as needed. In case of discomfort or inadvertent ingestion, seek medical attention immediately.
Last Update:2024-04-09 20:49:11